CluePoints

CluePoints is a leading software development company specializing in AI-powered Risk-Based Quality Management (RBQM) and data quality oversight solutions. Located at New Tech Centre, Avenue Albert Einstein 2A, Louvain-La-Neuve 1348, BE, and with an additional location at 1000 Continental Dr, Suite 240, King of Prussia, Pennsylvania 19406, US, CluePoints leverages the potential of artificial intelligence using advanced statistics and machine learning to determine the quality, accuracy, and integrity of clinical trial data.

Aligned with guidance from the FDA, EMA, ICH, and MHRA, CluePoints supports central and on-site monitoring, medical review, and quality risk management to drive a holistic risk-based strategy. The company is dedicated to ensuring positive clinical development outcomes, increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.

CluePoints is committed to innovation and excellence in software development. More details about the firm's activities and partnerships will be available soon, updated with insights directly from the company's management team. We invite the CluePoints management team to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking solutions.